GlassScriptPhysician profile
Prem K Chopra
NPI 1932134988
$1,973.60
in general payments reported to CMS, 2019-2025
24 companies · $219 in 2025
The $219 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $254 · 2021: $352 · 2022: $385 · 2023: $341 · 2024: $192 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $463.59 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $362.03 | 2019-2024 | Bexsero |
| Pfizer INC. | $201.49 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.88 | 2020-2021 | |
| Sanofi Pasteur INC. | $113.73 | 2019-2023 | |
| Seqirus USA INC | $81.83 | 2022-2025 | Flucelvax |
| Kaleo, INC. | $73.19 | 2019-2021 | |
| Tris Pharma INC | $62.19 | 2020-2022 | |
| Corium, LLC | $60.98 | 2022-2025 | Azstarys |
| Genentech USA, INC. | $55.15 | 2019-2020 | |
| Dermira, INC. | $51.72 | 2020 | |
| Gilead Sciences, INC. | $47.64 | 2019-2023 | |
| Organon LLC | $34.80 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $27.06 | 2025 | Kristalose |
| Phadia US INC. | $25.92 | 2025 | Immunocap |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $25.19 | 2025 | Doc Band |
| Chiesi USA, INC. | $25.01 | 2024 | Filsuvez |
| Supernus Pharmaceuticals, INC. | $24.61 | 2022 | |
| Kyowa Kirin, INC. | $23.92 | 2024 | Crysvita |
| Mission Pharmacal Company | $20.54 | 2019 | |
| Adlon Therapeutics L.P. | $16.36 | 2020 | |
| Neos Therapeutics, LP | $16.13 | 2019 | |
| Cipher Pharmaceuticals US LLC | $15.65 | 2025 | Natroba, Spinosad |
| Shire North American Group INC | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prem Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.